Dashboard Tools Market News Investing Ideas Pricing
Search 100,000+ stocks...
English EN
Deutsch DE Español ES
Sign Up
Log in
Starpharma Holdings Ltd banner

Starpharma Holdings Ltd
ASX:SPL

Watchlist Manager
Starpharma Holdings Ltd Logo
Starpharma Holdings Ltd
ASX:SPL
Watchlist
Price: 0.735 AUD 2.08% Market Closed
Market Cap: AU$350.6m
Write Note Create Alert Ask AI

Wall St Price Targets

SPL Price Targets Summary
Starpharma Holdings Ltd

Wall Street analysts forecast SPL stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for SPL is 1.275 AUD with a low forecast of 1.263 AUD and a high forecast of 1.313 AUD.

SPL Lowest Forecast
Wall Street Target
AU$1.263
72% Upside
SPL Average Forecast
Wall Street Target
AU$1.275
73% Upside
SPL Highest Forecast
Wall Street Target
AU$1.313
79% Upside
Lowest Forecast
Price Target
1.263 AUD
72% Upside
Average Forecast
Price Target
1.275 AUD
73% Upside
Highest Forecast
Price Target
1.313 AUD
79% Upside
Starpharma Holdings Ltd Competitors:
Price Targets
GTES
Gates Industrial Corporation PLC
31% Upside
GTES
Gates Industrial Corporation PLC
31% Upside

Revenue
Forecast

4% / Year
Past Growth
83% / Year
Estimated Growth
Estimates Accuracy
-52%
Average Miss
4% / Year
Past Growth
83% / Year
Estimated Growth
Estimates Accuracy
-52%
Average Miss

Over the last 13 years, the compound annual growth rate for Revenue has been 4%. The projected CAGR for the next 4 years is 83%.

What are analyst estimates?

Gross Profit
Forecast

N/A
Past Growth
-7% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
-7% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

The compound annual growth rate for Gross Profit over the next 11 years is -7%.

What are analyst estimates?

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
15%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
15%
Average Beat

What are analyst estimates?

Pre-Tax Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
25%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
25%
Average Beat

What are analyst estimates?

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
23%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
23%
Average Beat

What are analyst estimates?

Continue SPL Research

Summary
SPL intrinsic value, competitors valuation, and company profile.
DCF Valuation
SPL stock valuation using Discount Cash Flow valuation method.
Relative Valuation
SPL stock valuation using valuation multiples.
Wall St Estimates
SPL price targets and financial estimates made by Wall Street analysts.
Profitability
Detailed analysis of the company's profitability.
Solvency
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
SPL stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall St Estimates
Profitability
Solvency
Financials
Discount Rate
Other Starpharma Holdings Ltd listings:
OTC • USD
SPHRF
 OTC • USD
SPHRY
 F • EUR
PQ6
 F • EUR
PQ6A
 XMUN • EUR
PQ6
 SWB • EUR
PQ6
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is SPL's stock price target?
Price Target
1.275 AUD

According to Wall Street analysts, the average 1-year price target for SPL is 1.275 AUD with a low forecast of 1.263 AUD and a high forecast of 1.313 AUD.

What is the Revenue forecast for Starpharma Holdings Ltd?
Projected CAGR
83%

Over the last 13 years, the compound annual growth rate for Revenue has been 4%. The projected CAGR for the next 4 years is 83%.

What is the Gross Profit forecast for Starpharma Holdings Ltd?
Projected CAGR
-7%

The compound annual growth rate for Gross Profit over the next 11 years is -7%.

Back to Top
ALPHA SPREAD
Follow us
Join 356,100+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Valuation Backtest Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.

AI Assistant
Get AI-powered insights for any company or topic.
Open AI Assistant
Other Tools
Stock Screener
Discover stocks
Stock Comparison
Smarter decisions through side-by-side analysis
Intrinsic Value Calculator
Discover the true worth of your stocks
DCF Value Calculator
Harness the power of DCF

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett